# The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis

> **NCT00805285** · PHASE2 · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 1 (actual)

## Conditions studied

- Inflammatory Bowel Disease
- Ulcerative Colitis

## Interventions

- **DRUG:** Combination Oral Budesonide and Rectal Hydrocortisone

## Key facts

- **NCT ID:** NCT00805285
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2009-10
- **Final completion:** 2010-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study terminated due to insufficient enrollment
- **Last updated:** 2019-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00805285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00805285, "The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00805285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*